C5ORF24 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 5.70432590052405E-13 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.6592283103023E-12 |
Normal-vs-Stage2 |
4.154800E-04 |
Normal-vs-Stage3 |
4.461800E-03 |
Normal-vs-Stage4 |
5.100000E-01 |
Stage1-vs-Stage2 |
3.048600E-01 |
Stage1-vs-Stage3 |
2.404500E-02 |
Stage1-vs-Stage4 |
1.151760E-01 |
Stage2-vs-Stage3 |
4.641800E-01 |
Stage2-vs-Stage4 |
1.888960E-01 |
Stage3-vs-Stage4 |
4.094600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.9559909247846E-12 |
Normal-vs-AfricanAmerican |
6.69650002116384E-10 |
Normal-vs-Asian |
1.701460E-03 |
Caucasian-vs-AfricanAmerican |
9.574200E-01 |
Caucasian-vs-Asian |
6.814000E-01 |
AfricanAmerican-vs-Asian |
6.791200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.98570065840431E-14 |
Normal-vs-Female |
3.21579999962296E-07 |
Male-vs-Female |
1.701560E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
3.55490000003567E-06 |
Normal-vs-Extreme_Weight |
3.5527136788005E-15 |
Normal-vs-Obese |
2.26609999653959E-08 |
Normal-vs-Extreme_Obese |
1.79940000011314E-07 |
Normal_Weight-vs-Extreme_Weight |
2.591800E-01 |
Normal_Weight-vs-Obese |
8.204400E-01 |
Normal_Weight-vs-Extreme_Obese |
4.965200E-01 |
Extreme_Weight-vs-Obese |
7.235600E-02 |
Extreme_Weight-vs-Extreme_Obese |
8.293200E-01 |
Obese-vs-Extreme_Obese |
4.861600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
7.14410000046684E-07 |
Normal-vs-Age(41-60Yrs) |
5.63890001359368E-09 |
Normal-vs-Age(61-80Yrs) |
1.62703184258817E-12 |
Normal-vs-Age(81-100Yrs) |
6.55709999630716E-08 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.357400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.831400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.181800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.143700E-03 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.332400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.943600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
3.66373598126302E-15 |
Normal-VS-Type2 PRCC |
4.23339999999772E-05 |
Normal-VS-KIRP CIMP |
3.95210000003754E-06 |
Normal-VS-Unclassified PRCC |
1.765090E-04 |
Type1 PRCC-VS-Type2 PRCC |
5.043800E-03 |
Type1 PRCC-VS-KIRP CIMP |
6.818000E-01 |
Type1 PRCC-VS-Unclassified PRCC |
4.660400E-02 |
Type2 PRCC-VS-KIRP CIMP |
3.771600E-01 |
Type2 PRCC-VS-Unclassified PRCC |
7.714800E-01 |
KIRP CIMP-VS-Unclassified PRCC |
4.294200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
8.74100000158862E-08 |
Normal-vs-N1 |
3.432400E-02 |
Normal-vs-N2 |
1.674130E-02 |
N0-vs-N1 |
1.579990E-01 |
N0-vs-N2 |
6.634000E-01 |
N1-vs-N2 |
8.100200E-01 |
|
|